A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.
"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback